Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program (Englisch)
- Neue Suche nach: Beaton, D. E.
- Neue Suche nach: Dyer, S.
- Neue Suche nach: Jiang, D.
- Neue Suche nach: Sujic, R.
- Neue Suche nach: Slater, M.
- Neue Suche nach: Sale, J. E.
- Neue Suche nach: Bogoch, E. R.
- Neue Suche nach: The, O. F.
- Neue Suche nach: Beaton, D. E.
- Neue Suche nach: Dyer, S.
- Neue Suche nach: Jiang, D.
- Neue Suche nach: Sujic, R.
- Neue Suche nach: Slater, M.
- Neue Suche nach: Sale, J. E.
- Neue Suche nach: Bogoch, E. R.
- Neue Suche nach: The, O. F.
In:
OSTEOPOROSIS INTERNATIONAL
;
25
, 1
;
289-296
;
2014
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program
-
Beteiligte:Beaton, D. E. ( Autor:in ) / Dyer, S. ( Autor:in ) / Jiang, D. ( Autor:in ) / Sujic, R. ( Autor:in ) / Slater, M. ( Autor:in ) / Sale, J. E. ( Autor:in ) / Bogoch, E. R. ( Autor:in ) / The, O. F. ( Autor:in )
-
Erschienen in:OSTEOPOROSIS INTERNATIONAL ; 25, 1 ; 289-296
-
Verlag:
- Neue Suche nach: Springer Science + Business Media
-
Erscheinungsdatum:01.01.2014
-
Format / Umfang:8 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.716
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.716 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 25, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Comparison between various fracture risk assessment toolsLeslie, W. D. / Lix, L. M. et al. | 2014
- 23
-
Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic reviewNayak, S. / Edwards, D. L. / Saleh, A. A. / Greenspan, S. L. et al. | 2014
- 51
-
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fracturesSi, L. / Winzenberg, T. M. / Palmer, A. J. et al. | 2014
- 61
-
FRAX provides robust fracture prediction regardless of socioeconomic statusBrennan, S. L. / Leslie, W. D. / Lix, L. M. / Johansson, H. / Oden, A. / McCloskey, E. / Kanis, J. A. et al. | 2014
- 71
-
The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney diseaseJamal, S. A. / West, S. L. / Nickolas, T. L. et al. | 2014
- 77
-
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture TrialPrieto-Alhambra, D. / Judge, A. / Arden, N. K. / Cooper, C. / Lyles, K. W. / Javaid, M. K. et al. | 2014
- 85
-
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort studyGregson, C. L. / Dennison, E. M. / Compston, J. E. / Adami, S. / Adachi, J. D. / Anderson, F. A. / Boonen, S. / Chapurlat, R. / Díez-Pérez, A. / Greenspan, S. L. et al. | 2014
- 97
-
Association between hypertension and fragility fracture: a longitudinal studyYang, S. / Nguyen, N. D. / Center, J. R. / Eisman, J. A. / Nguyen, T. V. et al. | 2014
- 105
-
Association between use of benzodiazepines and risk of fractures: a meta-analysisXing, D. / Ma, X. L. / Ma, J. X. / Wang, J. / Yang, Y. / Chen, Y. et al. | 2014
- 121
-
β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effectsToulis, K. A. / Hemming, K. / Stergianos, S. / Nirantharakumar, K. / Bilezikian, J. P. et al. | 2014
- 131
-
Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS SwedenLewerin, C. / Nilsson-Ehle, H. / Jacobsson, S. / Johansson, H. / Sundh, V. / Karlsson, M. K. / Ljunggren, . / Lorentzon, M. / Kanis, J. A. / Lerner, U. H. et al. | 2014
- 141
-
Coffee, tea, and the risk of hip fracture: a meta-analysisSheng, J. / Qu, X. / Zhang, X. / Zhai, Z. / Li, H. / Liu, X. / Liu, G. / Zhu, Z. / Hao, Y. et al. | 2014
- 151
-
Fracture risk following bariatric surgery: a population-based studyNakamura, K. M. / Haglind, E. G. / Clowes, J. A. / Achenbach, S. J. / Atkinson, E. J. / Melton, L. J. / Kennel, K. A. et al. | 2014
- 159
-
Incidence and risk factors for hip fractures in dialysis patientsMaravic, M. / Ostertag, A. / Torres, P. U. / Cohen-Solal, M. et al. | 2014
- 167
-
Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and olderFinsterwald, M. / Sidelnikov, E. / Orav, E. J. / Dawson-Hughes, B. / Theiler, R. / Egli, A. / Platz, A. / Simmen, H. P. / Meier, C. / Grob, D. et al. | 2014
- 177
-
Exploring the determinants of fracture risk among individuals with spinal cord injuryLala, D. / Craven, B. C. / Thabane, L. / Papaioannou, A. / Adachi, J. D. / Popovic, M. R. / Giangregorio, L. M. et al. | 2014
- 187
-
Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adultsScott, D. / Hayes, A. / Sanders, K. M. / Aitken, D. / Ebeling, P. R. / Jones, G. et al. | 2014
- 195
-
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluationEekman, D. A. / Wee, M. M. / Coupé, V. M. / Erisek-Demirtas, S. / Kramer, M. H. / Lems, W. F. et al. | 2014
- 205
-
Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provincesCrilly, R. G. / Kloseck, M. / Chesworth, B. / Mequanint, S. / Sadowski, E. / Gilliland, J. et al. | 2014
- 211
-
Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008Siggeirsdottir, K. / Aspelund, T. / Jonsson, B. Y. / Mogensen, B. / Gudmundsson, E. F. / Gudnason, V. / Sigurdsson, G. et al. | 2014
- 221
-
Erratum to: Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008Siggeirsdottir, K. / Aspelund, T. / Jonsson, B. Y. / Mogensen, B. / Gudmundsson, E. F. / Gudnason, V. / Sigurdsson, G. et al. | 2014
- 223
-
Effect of increased fruit and vegetable consumption on bone turnover in older adults: a randomised controlled trialNeville, C. E. / Young, I. S. / Gilchrist, S. E. / McKinley, M. C. / Gibson, A. / Edgar, J. D. / Woodside, J. V. et al. | 2014
- 235
-
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fracturesJohansson, H. / Odén, A. / McCloskey, E. V. / Kanis, J. A. et al. | 2014
- 243
-
Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic rangeNassar, K. / Paternotte, S. / Kolta, S. / Fechtenbaum, J. / Roux, C. / Briot, K. et al. | 2014
- 251
-
Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography studyYang, L. / Udall, W. J. / McCloskey, E. V. / Eastell, R. et al. | 2014
- 265
-
Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition studyMori, T. / Ishii, S. / Greendale, G. A. / Cauley, J. A. / Sternfeld, B. / Crandall, C. J. / Han, W. / Karlamangla, A. S. et al. | 2014
- 273
-
Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?Brennan, S. L. / Leslie, W. D. / Lix, L. M. et al. | 2014
- 281
-
Non-pharmacological strategies used by patients at high risk for future fracture to manage fracture risk—a qualitative studySale, J. E. / Gignac, M. A. / Hawker, G. / Beaton, D. / Bogoch, E. / Webster, F. / Frankel, L. / Elliot-Gibson, V. et al. | 2014
- 289
-
Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening programBeaton, D. E. / Dyer, S. / Jiang, D. / Sujic, R. / Slater, M. / Sale, J. E. / Bogoch, E. R. / The, O. F. et al. | 2014
- 297
-
The Auckland calcium study: 5-year post-trial follow-upRadford, L. T. / Bolland, M. J. / Mason, B. / Horne, A. / Gamble, G. D. / Grey, A. / Reid, I. R. et al. | 2014
- 305
-
A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?Wood, A. D. / Secombes, K. R. / Thies, F. / Aucott, L. S. / Black, A. J. / Reid, D. M. / Mavroeidi, A. / Simpson, W. G. / Fraser, W. D. / Macdonald, H. M. et al. | 2014
- 317
-
Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone massZhang, J. / Delzell, E. / Curtis, J. R. / Hooven, F. / Gehlbach, S. H. / Anderson, F. A. / Saag, K. G. et al. | 2014
- 325
-
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithmKim, K. / Svedbom, A. / Luo, X. / Sutradhar, S. / Kanis, J. A. et al. | 2014
- 339
-
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosisHadji, P. / Felsenberg, D. / Amling, M. / Hofbauer, L. C. / Kandenwein, J. A. / Kurth, A. et al. | 2014
- 349
-
Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studiesMiller, P. D. / Recker, R. R. / Harris, S. / Silverman, S. / Felsenberg, D. / Reginster, J. / Day, B. M. / Barr, C. / Masanauskaite, D. et al. | 2014
- 359
-
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trialMeier, C. / Kraenzlin, C. / Friederich, N. F. / Wischer, T. / Grize, L. / Meier, C. R. / Kraenzlin, M. E. et al. | 2014
- 367
-
Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding studyNakamura, T. / Shiraki, M. / Fukunaga, M. / Tomomitsu, T. / Santora, A. C. / Tsai, R. / Fujimoto, G. / Nakagomi, M. / Tsubouchi, H. / Rosenberg, E. et al. | 2014
- 377
-
An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatideNiimi, R. / Kono, T. / Nishihara, A. / Hasegawa, M. / Matsumine, A. / Nakamura, T. / Sudo, A. et al. | 2014
- 385
-
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trialKlop, C. / Vries, F. / Vinks, T. / Kooij, M. J. / Staa, T. P. / Bijlsma, J. W. / Egberts, A. C. / Bouvy, M. L. et al. | 2014
- 393
-
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumabNeuprez, A. / Coste, S. / Rompen, E. / Crielaard, J. M. / Reginster, J. Y. et al. | 2014